γ-
Tocotrienol, a major component of the
tocotrienol-rich fraction of
palm oil, has been suggested to have
antioxidant and anticancer activity as well as potent chemopreventive effects on
tumor cells. In this study, the mechanisms underlying γ-
tocotrienol-mediated growth inhibition of human
carcinoma HT-29 cells were further investigated, especially in correlation with the involvement of β-
catenin/
T-cell factor (Tcf) signaling pathway. We found that γ-
tocotrienol could strongly suppress the transcriptional activity of β-
catenin/Tcf signaling pathway in HT-29 cells. γ-
Tocotrienol inhibited the expression level of total β-
catenin protein but did not significantly affect the phosphorylated β-
catenin level. Meanwhile, γ-
tocotrienol down-regulated the
protein level of nuclear β-
catenin and induced its redistribution to cell membrane. Furthermore, γ-
tocotrienol suppressed the expression of downstream target genes such as c-myc,
cyclin D1 and
survivin. The results demonstrated that γ-
tocotrienol-inhibited growth and -induced apoptosis in HT-29 cells were accompanied by significant inhibition of β-
catenin/Tcf signaling. Blocking the expression of β-
catenin with
small interfering RNA significantly suppressed the ability of γ-
tocotrienol to reduce viability and induce apoptosis in HT-29 cells. Thus, our data suggested that γ-
tocotrienol exerts its anticancer activity through β-
catenin/Tcf signaling, and β-
catenin is a target for γ-
tocotrienol in the Wnt/β-
catenin signaling pathway.